US56600D1072 - Common Stock
NASDAQ:MRVI (12/1/2022, 10:28:04 AM)-0.47 (-3.13%)
|GICS Sector||Health Care|
|GICS Industry||Life Sciences Tools & Services|
|Earnings (Last)||11-02 2022-11-02/amc||Earnings (Next)||02-21 2023-02-21|
|Ins Owners||0.6%||Inst Owners||98.98%|
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Maravai Lifesciences Holdings, Inc. is a life sciences company. The company is headquartered in San Diego, California and currently employs 600 full-time employees. The company went IPO on 2020-11-20. The firm provides products that enables the development of drug therapies, diagnostics, vaccines and support research on human diseases. The firm's segments include Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The company also provides research products for labeling and detecting proteins in cells and tissue samples. Its products include CleanCap, messenger ribonucleic acid (mRNA) and oligonucleotide. The Biologics Safety Testing focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing spectrum. The firm provides ultra-pure nucleotides to customers in the diagnostics, pharma, genomics and research markets.
MARAVAI LIFESCIENCES HLDGS-A
10770 Wateridge Circle Suite 200, Suite 200
San Diego CALIFORNIA 92121
CEO: Carl Hull
These two companies are facing short-term issues that are likely to give way to long-term success.
SAN DIEGO, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to...
SOUTHPORT, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading assay and...
Here you can normally see the latest stock twits on MRVI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.